Investigating how Chlamydia pneumoniae infection may influence Alzheimer's Disease

The role of Chlamydia pneumoniae infection in Alzheimer's Disease

NIH-funded research Cedars-Sinai Medical Center · NIH-10884175

This study is looking into whether a common lung infection called Chlamydia pneumoniae might play a role in making Alzheimer's Disease worse, and it aims to find new ways to help manage or prevent the disease for those affected.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-10884175 on NIH RePORTER

What this research studies

This research explores the potential link between Chlamydia pneumoniae infection and the progression of Alzheimer's Disease (AD). Researchers aim to understand how this common respiratory infection could contribute to the development or acceleration of AD pathology. By examining the presence of the bacteria in the brains of AD patients and studying the inflammatory responses it triggers, the research seeks to uncover new insights into the mechanisms of AD. This could lead to novel therapeutic approaches for managing or preventing Alzheimer's Disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with late-onset Alzheimer's Disease, particularly those with a history of respiratory infections.

Not a fit: Patients with early-onset Alzheimer's Disease or those without a history of Chlamydia pneumoniae infection may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new strategies for preventing or slowing the progression of Alzheimer's Disease.

How similar studies have performed: While the role of infections in Alzheimer's Disease has been previously explored, this specific investigation into Chlamydia pneumoniae is relatively novel and has not been extensively tested.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.